138P Cost-effectiveness of nivolumab and ipilimumab versus chemotherapy (with and without bevacizumab) in patients with unresectable malignant pleural mesothelioma in Switzerland

Autor:	M.C. Barbier, A. Fengler, O. Gautschi
Rok vydání:	2023
Předmět:	Pulmonary and Respiratory Medicine Oncology
Zdroj:	Journal of Thoracic Oncology. 18:S118
ISSN:	1556-0864
DOI:	10.1016/s1556-0864(23)00393-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7aa10b1c9d31b07ec254bb3be33ad25b https://doi.org/10.1016/s1556-0864(23)00393-3 Zobrazit plný text záznamu